Sanofi and Seagen announce collaboration to develop and commercialize multiple novel antibody-drug conjugates

The international community has implemented unprecedented sanctions to Russia.
Under the terms of the initial agreement, the Carisma Therapeutics manufacturing process will be transferred to the Novartis Cell Therapy Site in Morris Plains, U.S, starting in the coming days.